Abiopharma

Clinical trial NCT06700447: primary completion date: 2026-12-01 → 2025-10-16.

Clinical trial NCT07156565: enrollment: 30 → 48 participants.

Clinical trial NCT04787341 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-30 → 2026-05-28 3. enrollment: 214 → 213 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04802590 updates: 1. completion date: 2031-09-30 → 2030-03-02 2. primary completion date: 2028-03-31 → 2025-05-27

Clinical trial NCT07504601: start date: 2026-09-01 → 2026-09-02.

Clinical trial NCT05512390 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 154 → 39 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07780266 updates: 1. enrollment: 20 → 36 participants 2. intervention model: PARALLEL → CROSSOVER 3. masking: NONE → SINGLE

Clinical trial NCT06648889 updates: 1. completion date: 2028-08-01 → 2030-06-01 2. primary completion date: 2028-02-01 → 2029-06-01 3. enrollment: 40 → 28 participants

Clinical trial NCT00508547: enrollment: 15849 → 20167 participants.

Clinical trial NCT07735793: start date: 2026-07-27 → 2026-09-30.

Clinical trial NCT06321705: status: AVAILABLE → NO_LONGER_AVAILABLE.

Clinical trial NCT06261502 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-05-01 → 2025-09-01 3. completion date: 2027-12-01 → 2028-12-01 4. primary completion date: 2027-12-01 → 2028-07-01

Clinical trial NCT06559306: completion date: 2026-12-30 → 2027-04-15.

Clinical trial NCT06139406: completion date: 2026-08-31 → 2026-09-30.

Clinical trial NCT07304843: status: RECRUITING → ACTIVE_NOT_RECRUITING.